首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model.
【24h】

Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model.

机译:不同的免疫抑制剂对急性胰腺炎的影响:在改良动物模型中的比较研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Immunosuppressive drugs have been associated with the development and progression of acute pancreatitis after organ transplantation. Consequently, a reduction or a change in immunosuppressive therapy has been recommended once posttransplantation pancreatitis has been suspected. However, it is not known which of the available immunosuppressive agents is most harmful to the pancreas and which may be used safely in this situation. The objective of this study was to investigate the effect of different immunosuppressive drugs in various dosages on intrapancreatic protease activation, acinar cell necrosis, and mortality in an improved model of acute necrotizing pancreatitis in the rat. The rat model of acute necrotizing pancreatitis, like posttransplantation pancreatitis, is characterized by ischemia and microcirculatory disorders. METHOD: Acute pancreatitis was induced in rats by using a combination of low-dose controlled intraductal glycodeoxycholic acid superimposed on intravenous cerulein hyperstimulation. Six hours thereafter, animals were randomized to intravenous therapy with 2, 10, or 50 mg/kg/day prednisolone (PRED); 3, 15, or 60 mg/kg/day cyclosporine A (CsA); 10 mg/kg/day azathioprine (AZA); 0.6 mg/kg/day orthoclone OKT3 (OKT3); or saline. After 36 hr, surviving animals were killed to determine acinar cell necrosis and trypsinogen activation peptides levels (TAP) in blood and ascites. RESULTS: Compared with saline-treated control rats, animals treated with 60 mg/kg/day CsA developed significantly more acinar cell necrosis and had increased amounts of TAP in ascites. Likewise, there was more extensive acinar cell necrosis in animals subjected to AZA therapy. However, this was not associated with incremental TAP. Animals treated with 3 or 15 mg/kg/day CsA, OKT3, or PRED showed no significant changes in these target parameters. Animals given 10 or 50 mg/kg/day PRED even had decreased hematocrit values and produced significantly less ascites than animals in the other groups. CONCLUSION: The present results suggest that AZA and high doses of CsA aggravate acute pancreatitis and should, therefore, be avoided once posttransplantation pancreatitis has been suspected, whereas lower doses of CsA, OKT3, and PRED may be used safely. PRED can even be used at higher doses as may be required when graft rejection is suspected.
机译:背景:免疫抑制药物与器官移植后急性胰腺炎的发生和发展有关。因此,一旦怀疑移植后胰腺炎,建议减少或改变免疫抑制疗法。但是,尚不清楚哪种可用的免疫抑制剂对胰腺最有害,在这种情况下哪些可以安全使用。这项研究的目的是在改进的大鼠急性坏死性胰腺炎模型中研究不同剂量的不同免疫抑制药物对胰腺内蛋白酶激活,腺泡细胞坏死和死亡率的影响。像移植后胰腺炎一样,急性坏死性胰腺炎的大鼠模型具有局部缺血和微循环障碍的特征。方法:将低剂量控制的导管内糖脱氧胆酸与静脉注射铜绿素过度刺激相结合,诱发大鼠急性胰腺炎。此后六个小时,将动物随机分配至接受2、10或50 mg / kg /天泼尼松龙(PRED)静脉内治疗; 3、15或60 mg / kg /天的环孢素A(CsA); 10 mg / kg / day硫唑嘌呤(AZA); 0.6 mg / kg /天Orthoclone OKT3(OKT3);或盐水。 36小时后,杀死存活的动物以确定血液和腹水中的腺泡细胞坏死和胰蛋白酶原激活肽水平(TAP)。结果:与生理盐水对照组相比,接受60 mg / kg / day CsA处理的动物的腺泡细胞坏死明显增加,并且腹水中TAP的含量增加。同样,在接受AZA治疗的动物中,腺泡细胞坏死的范围也更大。但是,这与增量TAP无关。用3或15 mg / kg /天的CsA,OKT3或PRED处理的动物在这些目标参数上未显示任何明显变化。给予10或50 mg / kg /天PRED的动物甚至比其他组的动物具有更低的血细胞比容值并且产生的腹水明显更少。结论:目前的结果表明,AZA和高剂量的CsA加重急性胰腺炎,因此,一旦怀疑移植后胰腺炎,应避免使用,而较低剂量的CsA,OKT3和PRED可安全使用。当怀疑移植物排斥时,甚至可以以更高的剂量使用PRED。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号